Coronary microvascular disease (CMD) refers to the subset of disorders affecting the
structure and function of the coronary microcirculation, is prevalent in patients across a …

Aims This meta-analysis aims to quantify the association of reduced coronary flow with all-
cause mortality and major adverse cardiovascular events (MACE) across a broad range of …

Cochrane, Maria Crespo Leiro, Anne Dipchand, Brian Feingold, Kathleen Grady, Edward
Horn, Maryl Johnson, Donna Mancini, Sean Pinney, Heather Ross, Kari Wujcik, Andreas …

Chest pain in patients without obstructive coronary artery disease has been realized as a
frequent problem encountered in clinical practice. Invasive flow investigations have …

In the last decade, myocardial perfusion imaging (MPI) with PET has emerged to play a
pivotal role in the clinical routine process for the detection of hemodynamically significant …

Heart transplantation is an accepted treatment for select patients with end-stage heart
failure. Improvements to immunosuppressive therapies and patient management have …

Significant practice-changing developments have occurred in the care of heart
transplantation candidates and recipients over the past decade. This Canadian …

Background Cardiac allograft vasculopathy (CAV) is a major obstacle limiting long-term graft
survival. Effective noninvasive surveillance modalities reflecting both coronary artery and …

Cardiac allograft vasculopathy (CAV) is a unique accelerated form of coronary vascular
disease affecting heart transplant recipients. This complication is a significant contributor to …

Cardiac allograft vasculopathy (CAV) is a major cause of graft failure after cardiac
transplantation. CAV is characterized by diffuse involvement of epicardial coronary arteries …